Prodromes of first-episode psychosis: how can we challenge nonspecificity?

Simon AE, Ferrero FP, Merlo MC.

Compr Psychiatry. 2001 Sep-Oct;42(5):382-92.
Early detection and intervention for initial episodes of schizophrenia.
Falloon IR, Kydd RR, Coverdale JH, Laidlaw TM.
Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity
disorder.
Findling RL, Greenhill LL, McNamara NK, Demeter CA, Kotler LA, O'Riordan MA, Myers C,
Reed MD.
J Child Adolesc Psychopharmacol. 2007 Aug;17(4):433-45
Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial.
Reimherr FW, Hedges DW, Strong RE, Marchant BK, Williams ED.
Neuropsychiatr Dis Treat. 2005 Sep;1(3):245-51
Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with
intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
Cohen-Yavin I, Yoran-Hegesh R, Strous RD, Kotler M, Weizman A, Spivak B.
Clin Neuropharmacol. 2009 Jul-Aug;32(4):179-82
Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.
May DE, Kratochvil CJ.
Drugs. 2010;70(1):15-40. doi: 10.2165/11530540-000000000-00000
Guanfacine extended release in the treatment of attention-deficit/hyperactivity disorder.
Rostain AL.
Curr Psychiatry Rep. 2009 Oct;11(5):339-40. No abstract available.
Effect of acute and repeated treatment with desipramine or methylphenidate on serial reversal
learning in rats.
Seu E, David Jentsch J.
Neuropharmacology. 2009 Dec;57(7-8):665-72. Epub 2009 Aug 22.
An open trial of buspirone in the treatment of attention-deficit disorder.
Niederhofer H.
Hum Psychopharmacol. 2003 Aug;18(6):489-92.
A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents
with attention deficit and hyperactivity disorder.
Kahbazi M, Ghoreishi A, Rahiminejad F, Mohammadi MR, Kamalipour A, Akhondzadeh S.
Psychiatry Res. 2009 Aug 15;168(3):234-7. Epub 2009 May 12
Frequency of stimulant treatment and of stimulant-associated mania/hypomania in bipolar disorder
patients.
Wingo AP, Ghaemi SN.
Psychopharmacol Bull. 2008;41(4):37-47
Effects of transdermal nicotine on symptoms, moods, and cardiovascular activity in the everyday
lives of smokers and nonsmokers with attention-deficit/hyperactivity disorder.
Gehricke JG, Hong N, Whalen CK, Steinhoff K, Wigal TL.
Psychol Addict Behav. 2009 Dec;23(4):644-55
Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an
18-week, single-center, dose-escalating, prospective, open-label study.
Cubo E, Fernández Jaén A, Moreno C, Anaya B, González M, Kompoliti K.
Clin Ther. 2008 Jan;30(1):182-9.
Algorithms for the medical treatment of Attention-Deficit/Hyperactivity Disorder with specific co-
morbidities]
Frölich J, Lehmkuhl G, Döpfner M.
Z Kinder Jugendpsychiatr Psychother. 2010 Jan;38(1):7-20. Review. German.
http://www.adhdtraining.co.uk/usefulinfoclin.php